Virginia Cancer Specialists, PC, Arlington
Oncology & Hematology Associates of Southwest Virginia, Inc., DBA Blue Ridge Cancer Care, Blacksburg
Virginia Cancer Specialists, PC, Fairfax
dan 12 lainnya

Menerima pesertaFase 3

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07222800

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

NEXT Oncology Virginia, Fairfax

Menerima pesertaFase 1/2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT06128551

A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations

Next Oncology Virginia Cancer Specialist, Fairfax

Menerima pesertaFase 1/2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT07629960

A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer

University of Virginia Medical Center, Charlottesville
Mary Washington Healthcare, Fredericksburg
Hematology Oncology Associates of Fredericksburg Admin, Fredericksburg
dan 1 lainnya

Menerima pesertaFase 3

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT07284849

A Phase II Platform Study to Evaluate Treatment With Cemiplimab Monotherapy or Cemiplimab Plus Fianlimab or Other Novel Combinations in Patients With Colorectal Cancer With Minimal Residual Disease Following Definitive Surgery and Chemotherapy (EMPIRE)

University of Virginia Health, Charlottesville
Bon Secours St. Francis Medical Center, Midlothian
Virginia Commonwealth University - Massey, Richmond

Menerima pesertaFase 2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT07058012

Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps

Kaiser Permanente-Burke Medical Center, Burke
Kaiser Permanente Tysons Corner Medical Center, McLean
VCU Massey Cancer Center at Stony Point, Richmond
dan 3 lainnya

Menerima peserta

Usia 45 hingga 70 · Semua jenis kelamin · Diperbarui 2 Sep 2026 · NCT05080673

Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease

Kaiser Permanente-Burke Medical Center, Burke
Cancer Specialists of Tidewater Limited, Chesapeake
Peninsula Cancer Institute-Gloucester, Gloucester
dan 15 lainnya

Menerima pesertaFase 2/3

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Sep 2026 · NCT05174169

A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer

NEXT Oncology, Fairfax

Menerima pesertaFase 1

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 26 Agu 2026 · NCT07321106

Shield Post-Approval Study Protocol

Tidewater Physician Multispecialty Group Clinical Research, Williamsburg

Menerima pesertaStudi observasionalSukarelawan sehat diterima

Usia 45 hingga 81 · Semua jenis kelamin · Diperbarui 7 Agu 2026 · NCT06880055

A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation

NEXT Virginia, Fairfax

Menerima pesertaFase 1

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Jun 2026 · NCT07458347

A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (FRUITFUL)

Virginia Oncology Associates, Norfolk
Blue Ridge Cancer Care (Oncology & Hematology Associates of Southwest VA), Salem

Menerima pesertaFase 2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 12 Jun 2026 · NCT07011576

A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations

Research Site, Fairfax

Menerima pesertaFase 1

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Jun 2026 · NCT06835569

Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

NEXT Oncology Virginia, Fairfax

Menerima pesertaFase 1

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 3 Jun 2026 · NCT06040541

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

Next Oncology Virginia, Fairfax

Menerima pesertaFase 1/2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Mei 2026 · NCT05379985

Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors

NEXT, Virginia, Fairfax

Menerima pesertaFase 1/2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Feb 2026 · NCT07145255

Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer

GSK Investigational Site, Richmond

Menerima pesertaFase 3

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Jan 2026 · NCT05855200

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Massive Bio SYNERGY-AI site, Charlottesville

Menerima pesertaStudi observasional

Semua usia · Semua jenis kelamin · Diperbarui 28 Okt 2025 · NCT03452774

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.